TrialHuman vaccines & immunotherapeutics2014

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study.

Barbara Romanowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.